Cardiovascular, metabolic, and hormonal responses to noradrenaline in diabetic patients with autonomic neuropathy

Diabetic Medicine

Volumn 13, Issue 11, 1996, Pages 983-989

  Dejgaard, A ^a,b   Andersen, P ^a   Hvidberg, A ^a   Hilsted, J ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

adrenoreceptors; Autonomic neuropathy; Denervation hypersensitivity; Insulin dependent diabetes mellitus; Noradrenaline; Peripheral vascular resistance

Indexed keywords

3 HYDROXYBUTYRIC ACID; ADRENALIN; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; GLYCEROL; GROWTH HORMONE; HYDROCORTISONE; INSULIN; LACTIC ACID; NORADRENALIN; PANCREAS POLYPEPTIDE;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENERVATION; FEMALE; HEART OUTPUT; HEART RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PATHOGENESIS; VASCULAR RESISTANCE;

3-HYDROXYBUTYRIC ACID; ADRENERGIC ALPHA-AGONISTS; ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIAC OUTPUT; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; EPINEPHRINE; FEMALE; GLYCEROL; HEART RATE; HEMODYNAMIC PROCESSES; HORMONES; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYDROXYBUTYRATES; INFUSIONS, INTRAVENOUS; INSULIN; LACTATES; MALE; MIDDLE AGED; NOREPINEPHRINE; PANCREATIC POLYPEPTIDE; REFERENCE VALUES; SPLANCHNIC CIRCULATION; VASCULAR RESISTANCE;

EID: 0029806333     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199611)13:11<983::AID-DIA271>3.0.CO;2-7     Document Type: Article

References (39)

1. Hilsted J, Low PA. Diabetic autonomic neuropathy. In: Low PA, ed. Clinical Autonomic Disorders, Evaluation and Management. Boston: Little, Brown and Company, 1993, 423-443.
2. Ewing DJ, Boland O, Neilson JMM, Cho CG, Clarke BF. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia 1991; 34: 182-185.
3. Hilsted J. Blood pressure regulation in diabetic autonomic neuropathy. Clin Physiol 1985; 5 (suppl 5): 49-58.
4. Polinsky RJ, Goldstein DS, Brown RT, Keiser HR, Kopin IJ. Decreased sympathetic neuronal uptake in idiopathic orthostatic hypotension. Ann Neurol 1985; 18: 48-53.
5. Engelman K, Mueller PS, Horwitz D, Sjoerdsma A. Denervation hypersensitivity of adipose tissue in idiopathic orthostatic hypotension. Lancet 1964; II: 927-30.
6. Kontos HA, Richardson DW, Norvell JE. Norepinephrine depletion in idiopathic orthostatic hypotension. Ann Intern Med 1975; 82: 336-341.
7. Davies B, Sudera D, Sagnella G, Saviotti EM, Mathias C, Bannister R. Increased numbers of alpha receptors in sympathetic denervation supersensitivity in man. J Clin Invest 1982; 69: 779-784.
8. Hui KKP, Conolly ME. Increased numbers of beta receptors in orthostatic hypotension due to autonomic dysfunction. N Engl J Med 1981; 304: 1473-1476.
9. Mathias CJ, Frankel HL. Autonomic disturbances in spinal cord lesions. In: Bannister R, Mathias CJ, eds. Autonomic Failure: a Text-book of Clinical Disorders of the Autonomic Nervous System, 3rd edn. Oxford: Oxford Medical Publications, 1992: 839-881.
10. 2-adrenergic receptors on platelet membranes from diabetic patients with autonomic neuropathy and orthostatic hypotension. J Clin Endocrinol Metab 1986; 63: 906-912.
11. Dejgaard A, Liggett SB, Christensen NJ, Cryer PE, Hilsted J. Adrenergic receptors are a fallible index of adrenergic denervation hypersensitivity. Scand J Clin Lab Invest 1991; 51: 659-666.
12. Dejgaard J, Hilsted J, Christensen NJ. Noradrenaline and isoproterenol kinetics in diabetic patients with and without autonomic neuropathy. Diabetologia 1986; 29: 773-777.
13. Hilsted J, Richter E, Madsbad S, Tronier B, Christensen NJ, Hildebrandt P. Metabolic and cardiovascular responses to epinephrine in diabetic autonomic neuropathy. N Engl J Med 1987; 317: 421-426.
14. Barany FR. Abnormal vascular reactions in diabetes mellitus: a clinical physiological study. Acta Med Scand (suppl) 1955; 304: 1-128.
15. Moorhouse JA, Carter SA, Doupe J. Vascular responses in diabetic peripheral neuropathy. Br Med J 1966; 1: 883-888.
16. Scobie N, Rogers PT, Brown PM, Godfrey H, Sönksen PH. Supersensitivity to both tyramine and noradrenaline in diabetic autonomic neuropathy. J Neurol Neurosurg Psychiatry 1987; 50: 275-278.
17. Hilsted J. Testing for autonomic neuropathy. Ann Clin Res 1984; 16: 128-135.
18. Andersen HB, Jensen EW, Madsbad S, Nielsen SL, Burcharth F, Christensen NJ. Sham-feeding decreases cardiac output in normal subjects. Clin Physiol 1992; 12: 439-442.
19. 2 tensions by rebreathing. J Appl Physiol 1956; 9: 25-29.
20. Rowell LB, Blackmon JR, Bruce RA. Indocyanine green clearance and estimated hepatic blood flow during mild to maximal exercise in upright man. J Clin Invest 1964; 43: 1677-1690.
21. Christensen NJ, Vestergaard P, Sørensen T, Rafaelsen OJ. Cerebrospinal fluid adrenaline and noradrenaline in depressed patients. Acta Psychiatr Scand 1980; 61: 178-182.
22. Hilsted J, Madsbad S, Krarup T, Sestoft L, Christensen NJ, Tronier B. Hormonal, metabolic, and cardiovascular responses to hypoglycemia in diabetic autonomic neuropathy. Diabetes 1981; 30: 626-633.
23. Rizza RA, Cryer PE, Gerich JE. Role of glucagon, catecholamines, and growth hormone in human counter-regulation. Effects of somatostatin and combined α- and β-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. J Clin Invest 1979; 64: 62-71.
24. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 1959; 82: 420-430.
25. De Bodo RC, Steele R, Altszuler N, Dunn A, Bishop JS. On the hormonal regulation of carbohydrate metabolism; studies with C14 glucose. Recent Prog Horm Res 1963; 19: 445-488.
26. Jennrich RI, Schluchter MD. Unbalanced repeated measures models with structured covariance matrices. Biometrics 1986; 42: 805-820.
27. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 38: 963-974.
28. Silverberg AB, Shah SD, Haymond MW. Norepinephrine: hormone and neutrotransmitter in man. Am J Physiol 1978; 234: E252-E256.
29. Goldenberg M, Pines KL, Baldwin EDF, Greene DG, Roh CE. The hemodynamic response of man to nor-epinephrine and epinephrine and its relation to the problem of hypertension. Am J Med 1948; 5: 792-806.
30. Bodmer CW, Patrick AW, How TV, Williams G. Exaggerated sensitivity to NE-induced vasoconstriction in IDDM patients with microalbuminuria. Diabetes 1992; 41: 209-214.
31. Mølgaard H, Christensen PD, Hermansen K. Early recognition of autonomic dysfunction in microalbuminuria: significance for cardiovascular mortality in diabetes mellitus. Diabetologia 1994; 37: 788-796.
32. Wahrenberg H, Arner P, Adamsson U, Lins PE, Dannfelt AJ, Østman J. Increased lipolytic sensitivity to catecholamines in diabetic patients with severe autonomic neuropathy. J Intern Med 1990; 227: 309-316.
33. Liggett SB, Marker JC, Shah SD, Roper CL, Cryer PE. Direct relationship between mononuclear leucocyte and lung β-adrenergic receptors and apparent reciprocal regulation of extravascular, but not intravascular, α- and β-adrenergic receptors by the sympathochromaffin system in humans. J Clin Invest 1988; 82: 48-56.
34. 2-adrenoceptors from diabetic patients with orthostatic hypotension. J Clin Endocrinol Metab 1990; 71: 311-317.
35. Polinsky RJ. Neuropharmacological investigation of autonomic failure. In: Bannister R, Mathias CJ, eds. Autonomic Failure: a Textbook of Clinical Disorders of the Autonomic Nervous System, 3rd edn. Oxford: Oxford Medical Publications, 1992: 334-358.
36. Polinsky RJ, Kopin IJ, Ebert MH, Weise V. Pharmacologic distinction of different orthostatic hypotension syndromes. Neurology 1981; 31: 1-7.
37. Bannister R, Crowe R, Eames R, Rosenthal T, Sever P. Defective cardiovacular reflexes and supersensitivity to sympathomimetic drugs in autonomic failure. Brain 1979; 102: 163-176.
38. Eichler H, Blaschke F, Kraemer FB, Ford GA, Blöchldaum B, Hoffman BB. Responsiveness of superficial hand veins to α-adrenoceptor agonists in insulin-dependent diabetic patients Clin Sci 1992; 82: 163-168.
39. 2-adrenoceptor-mediated vasoconstriction in insulin dependent diabetic patients with microalbuminuria. Clin Sci 1995; 88: 421-426.